ArticleAmerican health & drug benefits2017

Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends.

Christopher B Atzinger et al.PubMed ↗Full text ↗

No numbers read from the abstract.